Juan Antonio C. R.
- Country
- Spain
- Department
- Neurology
Research Overview
- Evaluation of Hemodynamic Optimization Protocols Using Urapidil, Phenylephrine Hydrochloride, and Labetalol Hydrochloride in Acute Ischemic Stroke Post-Endovascular Therapy
- Evaluation of Dabigatran Etexilate, Apixaban, Edoxaban, and Drug Combination for Secondary Prevention in Acute Ischemic Stroke Patients Without Atrial Fibrillation
Data & Insights
Has run more than one trial at 2 of 11 partner sites.
Specializations
Stroke Prevention Research
This investigator specializes in secondary stroke prevention strategies, with particular emphasis on innovative approaches in patients with acute ischemic stroke. Their research explores the relationship between biomarkers and stroke recurrence risk.
- Ischemic Stroke Management
- Preventive Cardiology
- Biomarker-guided Therapy
The investigator's work focuses on evaluating novel therapeutic strategies for stroke prevention using proatrial natriuretic peptide as a diagnostic tool.
Cardiovascular Biomarkers
The investigator's expertise extends to the study of cardiovascular biomarkers, particularly focusing on their role in predicting and preventing adverse cardiac events in stroke patients.
- Natriuretic Peptide Research
- Cardiac Monitoring
- Risk Stratification
Their research explores the clinical applications of midregional proatrial natriuretic peptide in cardiovascular risk assessment.
Antithrombotic Therapy
This investigator studies advanced antithrombotic treatments, comparing the effectiveness of different therapeutic approaches in stroke prevention.
- Anticoagulation Therapy
- Antiplatelet Treatments
- Personalized Medicine Approaches
Their work involves evaluating direct oral anticoagulants against conventional antiplatelet therapy in specific patient populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.